cro.directory
← Compare landing

KCAS Bio vs Oncodesign Services

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/kcasbio/oncodesign-services

CategoryKCAS BioOncodesign Services
Listed sitecrocro
SummaryLeading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
Services
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Biomarker Assays
  • Immunogenicity Assays (ADA / NAb)
  • Flow Cytometry Services
  • Central Laboratory Services
  • Immunology & Inflammation Services
  • Virology Services
  • Microbiology Services
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • Translational Research
  • Discovery Research
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Clinical Imaging Core Lab
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • GLP Toxicology
  • Safety Pharmacology
  • Translational Research
  • Preclinical In Vitro Studies
  • Regulatory Affairs
  • LC-MS Bioanalysis (Small Molecule)
  • High-Throughput Screening
  • Genetic Toxicology
  • Computational & In-Silico Drug Discovery
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
Indications
  • Immunology
  • Cardiovascular
  • Dermatology
  • Gastroenterology
  • Infectious Disease
  • Metabolic
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Respiratory
  • Nephrology
  • Oncology
  • Immunology
  • Infectious Disease
  • Dermatology
  • Gastroenterology
  • Nephrology
  • Metabolic
  • Rare Disease
  • Respiratory
Locations
  • Kansas City, Kansas City, KS, USA
  • Philadelphia, Philadelphia, PA, USA
  • Lyon, Lyon, France
  • Melbourne, Melbourne, Australia
  • United States, US, United States
  • Europe, EU, Europe
  • Australia, Australia
  • Headquarters, Dijon, Bourgogne-Franche-Comté, France
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.